Reichelsheim, Germany

Rolf Bergmann

This inventor holds 22 USPTO granted patents, primarily in Chroman Derivatives. Top assignees: Merck Patent Gesellschaft MIT Beschrankter Haftung, E. Merck, Patentabteilung, Merck Patent Gesellschaft. Active years: 1976-2000.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Rolf Bergmann. Retrieved from https://idiyas.com/inventor/rolf-bergmann

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 5.3

ph-index = 10

Forward Citations = 285(Granted Patents)


Location History:

  • Darmstadt, DE (1976 - 1981)
  • Reichelsheim, DE (1987 - 2000)

Company Filing History:


Years Active: 1976-2000

Loading Chart...
Areas of Expertise:
Chroman Derivatives
Pyridaziny Compounds
Tetralin Compounds
Cardiovascular Effects
Hydroxyindole Derivatives
Dihydropyridines
Penicillins
Tetracyclic Compounds
Benzoxazines
Oxodihydropyridines
Cephalosporins
Pyridone-Acetic Acid
22 patents (USPTO):Explore Patents

Title: **Rolf Bergmann: Innovator in Cardiovascular Research**

Introduction

Rolf Bergmann, based in Reichelsheim, Germany, is an accomplished inventor with a remarkable portfolio of 22 patents. His contributions to the field of cardiovascular research have garnered attention, making him a significant figure in the domain of medicinal chemistry.

Latest Patents

Bergmann's latest patents focus on chroman derivatives, specifically those with the formula that includes defined groups R¹ to R⁸. These derivatives and their salts are noted for their effects on the cardiovascular system, showcasing his ongoing commitment to advancing medical science and developing effective treatments.

Career Highlights

Throughout his career, Rolf Bergmann has worked with notable companies in the pharmaceutical industry, including the Merck Patent Gesellschaft mit beschränkter Haftung and Merck Patent Gesellschaft. His work at these institutions has played a crucial role in the development of innovative solutions aimed at improving heart health.

Collaborations

Collaboration has been a key aspect of Bergmann's professional journey. He has worked alongside esteemed colleagues such as Rolf Gericke and Manfred Baumgarth, contributing to various research efforts that emphasize the importance of teamwork in scientific innovation.

Conclusion

In summary, Rolf Bergmann stands out as a leading innovator whose patents continue to influence the cardiovascular field. His dedication to research and collaboration reflects a deep commitment to advancing health solutions that can significantly benefit individuals with cardiovascular issues. With an impressive track record and ongoing contributions, Bergmann remains a vital presence in the realm of medical inventions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…